Author:
Adhikari Lokesh, ,Kumar Nitin,Saha Abhijit,Semalty Ajay,Semalty Mona
Abstract
Herbal drug naringenin is well known for its anti-cancer, anti-oxidant, anti-inflammatory activities, as carbohydrate metabolism promoter, immunity system modulator, BCRP/ABCG2 inhibitor, hormone substitute and hormone antagonist since decades. However, use of naringenin as pharmaceutical aid is hindered due to its low aqueous solubility. In the present study, β-cyclodextrin and hydroxy propyl -β- cyclodextrin based biocompatible nanoforms were developed by the exploitation of self-assembly properties of cyclodextrins in aqueous media using sodium dodecyl sulphate and Pluronic F108 as co-surfactants. Prepared formulations were evaluated for various parameters such as particle size, zeta potential, polydispersity index, percent encapsulation efficiency, drug solubility and in vitro permeation studies. Particles present in all the formulations were not greater than the 161.2 nm with surface charge up to -24.8 mV and highest polydispersity index of 0.739. Aqueous solubility of drugs in prepared formulations was increased by 4 fold. Drug permeability was increased twice of free drug naringenin. It was concluded that the cyclodextrin based biocompatible nanosystems can be developed in the improvement of aqueous solubility and hence the bioavailability of herbal drugs.
Publisher
Indian Drug Manufacturers' Association (IDMA)
Subject
Drug Discovery,Pharmaceutical Science,Pharmacology
Reference22 articles.
1. 1. Wilczewska A. Z., Niemirowicz K., Markiewicz K. H. and Car H.: Nanoparticles as drug delivery systems. Pharmacol. Rep., 2012, 64, 1020-1037.
2. 2. III R.O.W. and Vaughn J. M.: Nanoparticle Engineering, in: Swarbrick, James (PharmaceuTech, Inc., Pinehurst, North Carolinia, U. (Eds.), Encyclopedia of Pharmaceutical Technology., Informa Healthcare USA, Inc., 270 Madison Avenue New York, NY, 2007, 2384-2398.
3. 3. Rizvi S. A. A. and Saleh A.M.: Applications of nanoparticle systems in drug delivery technology. Saudi Pharm. J., 2018.
4. 4. Mudshinge S. R., Deore A. B., Patil S. and Bhalgat C. M.: Nanoparticles: Emerging carriers for drug delivery. Saudi Pharm. J., 2011.
5. 5. WHO | WHO traditional medicine strategy: 2014-2023, n.d. WHO. URL http://www.who.int/medicines/publications/traditional/trm_strategy14_23/en/ (Accessed date: 21.06.2019).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献